Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Memory Pharmaceuticals patents

Patents where

Current Assignee

Name

‌

Memory Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7358057 QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells	Patent 7358057 was granted and assigned to Memory Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7358057	April 15, 2008
‌ US Patent 7902217 Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof	Patent 7902217 was granted and assigned to Memory Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7902217	March 8, 2011
‌ US Patent 7429664 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof	Patent 7429664 was granted and assigned to Memory Pharmaceuticals on September, 2008 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7429664	September 30, 2008
‌ US Patent 7396833 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof	Patent 7396833 was granted and assigned to Memory Pharmaceuticals on July, 2008 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7396833	July 8, 2008
‌ US Patent 7632831 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof	Patent 7632831 was granted and assigned to Memory Pharmaceuticals on December, 2009 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7632831	December 15, 2009
‌ US Patent 7625924 Nicotinic alpha-7 receptor ligands and preparation and uses thereof	Patent 7625924 was granted and assigned to Memory Pharmaceuticals on December, 2009 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7625924	December 1, 2009
‌ US Patent 7235579 Phosphodiesterase 4 inhibitors	Patent 7235579 was granted and assigned to Memory Pharmaceuticals on June, 2007 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7235579	June 26, 2007
‌ US Patent 7495017 Phosphodiesterase 4 inhibitors	Patent 7495017 was granted and assigned to Memory Pharmaceuticals on February, 2009 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7495017	February 24, 2009
‌ US Patent 7153871 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs	Patent 7153871 was granted and assigned to Memory Pharmaceuticals on December, 2006 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7153871	December 26, 2006
‌ US Patent 7205320 Phosphodiesterase 4 inhibitors	Patent 7205320 was granted and assigned to Memory Pharmaceuticals on April, 2007 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7205320	April 17, 2007
‌ US Patent 8691841 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof	Patent 8691841 was granted and assigned to Memory Pharmaceuticals on April, 2014 by the United States Patent and Trademark Office.	‌ Memory Pharmaceuticals	‌ Memory Pharmaceuticals	United States Patent and Trademark Office	8691841	April 8, 2014
‌ US Patent 7244745 Heterocyclic compounds, methods for the preparation thereof, and uses thereof	Patent 7244745 was granted and assigned to Memory Pharmaceuticals on July, 2007 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7244745	July 17, 2007
‌ US Patent 7790722 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof	Patent 7790722 was granted and assigned to Memory Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7790722	September 7, 2010
‌ US Patent 7932248 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof	Patent 7932248 was granted and assigned to Memory Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7932248	April 26, 2011
‌ US Patent 8106066 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof	Patent 8106066 was granted and assigned to Memory Pharmaceuticals on January, 2012 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	8106066	January 31, 2012
‌ US Patent 7696198 Phosphodiesterase 4 inhibitors	Patent 7696198 was granted and assigned to Memory Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7696198	April 13, 2010
‌ US Patent 7964600 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof	Patent 7964600 was granted and assigned to Memory Pharmaceuticals on June, 2011 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7964600	June 21, 2011
‌ US Patent 8486937 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and use thereof	Patent 8486937 was granted and assigned to Memory Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	8486937	July 16, 2013
‌ US Patent 8158629 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof	Patent 8158629 was granted and assigned to Memory Pharmaceuticals on April, 2012 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	8158629	April 17, 2012
‌ US Patent 7700630 Heterocyclic compounds, methods for the preparation thereof, and uses thereof	Patent 7700630 was granted and assigned to Memory Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7700630	April 20, 2010
‌ US Patent 7696229 Compounds having 5-HT6 receptor affinity	Patent 7696229 was granted and assigned to Memory Pharmaceuticals on April, 2010 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7696229	April 13, 2010
‌ US Patent 7994199 Heterocyclic compounds, methods for the preparation thereof, and uses thereof	Patent 7994199 was granted and assigned to Memory Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7994199	August 9, 2011
‌ US Patent 8252811 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof	Patent 8252811 was granted and assigned to Memory Pharmaceuticals on August, 2012 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	8252811	August 28, 2012
‌ US Patent 7943773 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof	Patent 7943773 was granted and assigned to Memory Pharmaceuticals on May, 2011 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7943773	May 17, 2011
‌ US Patent 7342021 Phosphodiesterase 4 inhibitors	Patent 7342021 was granted and assigned to Memory Pharmaceuticals on March, 2008 by the United States Patent and Trademark Office.		‌ Memory Pharmaceuticals	United States Patent and Trademark Office	7342021	March 11, 2008

Results per page:

38 results

0 selected

38 results

0 selected